These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 16244283)
1. Differentiation of residual tumor from benign periablational tissues after radiofrequency ablation: the role of MR imaging contrast agents. Ni Y; Chen F; Marchal G Radiology; 2005 Nov; 237(2):745-7; author reply 748-9. PubMed ID: 16244283 [No Abstract] [Full Text] [Related]
2. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor. Kim TJ; Moon WK; Cha JH; Goo JM; Lee KH; Kim KH; Lee JW; Han JG; Weinmann HJ; Chang KH Radiology; 2005 Feb; 234(2):423-30. PubMed ID: 15591437 [TBL] [Abstract][Full Text] [Related]
3. Science to practice: can we differentiate residual untreated tumor from tissue responses to heat following thermal tumor ablation? Goldberg SN Radiology; 2005 Feb; 234(2):317-8. PubMed ID: 15670988 [No Abstract] [Full Text] [Related]
4. Dynamic contrast-enhanced MR imaging of VX2 carcinomas after X-irradiation in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent. Kim YH; Choi BI; Cho WH; Lim S; Moon WK; Han JK; Weinmann HJ; Chang KH Invest Radiol; 2003 Sep; 38(9):539-49. PubMed ID: 12960523 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging for hepatic radiofrequency ablation. Clasen S; Boss A; Schmidt D; Fritz J; Schraml C; Claussen CD; Pereira PL Eur J Radiol; 2006 Aug; 59(2):140-8. PubMed ID: 16716553 [TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: comparison of macromolecular contrast agent and gadopentetate dimeglumine. Lee JW; Moon WK; Weinmann HJ; Kim SJ; Kim JH; Park SH; Kim TJ; Yoon CJ; Kim YH; Cho EY; Ha SW; Kang WS; Chang KH Radiology; 2003 Oct; 229(1):132-9. PubMed ID: 14519873 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of residual acoustic schwannoma using gadolinium-DTPA enhanced magnetic resonance imaging with the fat suppression technique. Battista RA; Bojrab DI; Wang AM Am J Otol; 1995 Sep; 16(5):628-33. PubMed ID: 8588668 [TBL] [Abstract][Full Text] [Related]
8. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery]. Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304 [TBL] [Abstract][Full Text] [Related]
10. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging. Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147 [TBL] [Abstract][Full Text] [Related]
11. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285 [TBL] [Abstract][Full Text] [Related]
12. Porphyrin-containing polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents. Yan GP; Li Z; Xu W; Zhou CK; Yang L; Zhang Q; Li L; Liu F; Han L; Ge YX; Guo JF Int J Pharm; 2011 Apr; 407(1-2):119-25. PubMed ID: 21272626 [TBL] [Abstract][Full Text] [Related]
13. MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid. Bathe OF; Mahallati H J Surg Oncol; 2007 Jun; 95(8):670-3. PubMed ID: 17345591 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of glomus jugulare tumor recurrence with dynamic contrast medium flow in MRI]. Greess H; Bentzien S; Gjuric M; Lell M; Lenz M; Bautz W Rofo; 2000 Sep; 172(9):753-8. PubMed ID: 11079088 [TBL] [Abstract][Full Text] [Related]
15. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599 [TBL] [Abstract][Full Text] [Related]
16. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice. Ye J; Xu YK; Liu X; Lü GS Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514 [TBL] [Abstract][Full Text] [Related]